These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25979127)

  • 1. Discontinuation of memantine standard release and its impact on patient therapy.
    Mondiello T; Lam S
    Consult Pharm; 2015 May; 30(5):283-6. PubMed ID: 25979127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memantine extended release (28 mg once daily): a review of its use in Alzheimer's disease.
    Plosker GL
    Drugs; 2015 May; 75(8):887-97. PubMed ID: 25899711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Product Life-Cycle Management as Anticompetitive Behavior: The Case of Memantine.
    Capati VC; Kesselheim AS
    J Manag Care Spec Pharm; 2016 Apr; 22(4):339-44. PubMed ID: 27023687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease.
    Bassil N; Thaipisuttikul P; Grossberg GT
    Expert Opin Pharmacother; 2010 Jul; 11(10):1765-71. PubMed ID: 20540654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmaceutical answer to nonadherence: Once weekly oral memantine for Alzheimer's disease.
    Kanasty R; Low S; Bhise N; Yang J; Peeke E; Schwarz M; Wright J; Carter B; Moorthy S; Grant T; DeBenedictis B; Bishoff M; Simses C; Bellinger AM
    J Control Release; 2019 Jun; 303():34-41. PubMed ID: 30928488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White paper on expanding the role of pharmacists in caring for individuals with Alzheimer's disease: APhA Foundation Coordinating Council to Improve Collaboration in Supporting Patients with Alzheimer's Disease.
    Skelton JB
    J Am Pharm Assoc (2003); 2008; 48(6):715-21. PubMed ID: 19019799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Changing Landscape of Consultant Pharmacy Part 1 of 2.
    Martin CM
    Consult Pharm; 2015 Dec; 30(12):688-93. PubMed ID: 26671268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assisted Living Facilities: The Next Frontier for Consultant Pharmacists.
    Coulson E; Blaszczyk AT
    Consult Pharm; 2016 Feb; 31(2):107-11. PubMed ID: 26842688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial oversight of medication use: an expanded role for consultant pharmacists.
    Stefanacci RG
    Consult Pharm; 2012 Apr; 27(4):290-5. PubMed ID: 22498989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memantine (Namenda) for moderate to severe Alzheimer's disease.
    Ables AZ
    Am Fam Physician; 2004 Mar; 69(6):1491-2. PubMed ID: 15053415
    [No Abstract]   [Full Text] [Related]  

  • 11. Current advances in transdermal delivery of drugs for Alzheimer's disease.
    Nguyen TT; Giau VV; Vo TK
    Indian J Pharmacol; 2017; 49(2):145-154. PubMed ID: 28706327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Memantine brakes Alzheimer's dementia. The NMDA antagonist is effective in severe cases, too].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():21. PubMed ID: 14579479
    [No Abstract]   [Full Text] [Related]  

  • 13. Memantine: pharmacological properties and clinical uses.
    Kumar S
    Neurol India; 2004 Sep; 52(3):307-9. PubMed ID: 15472417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The consultant pharmacist's expanded role in nutrition management.
    Martin CM
    Consult Pharm; 2009 Jun; 24(6):414-21. PubMed ID: 19555152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Samuel W. Kidder: defining the role of consultant pharmacy.
    Bloom MZ
    Consult Pharm; 2012 Dec; 27(12):844-7. PubMed ID: 23229072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memantine-induced chorea and dystonia.
    Borges LG; Bonakdarpour B
    Pract Neurol; 2017 Apr; 17(2):133-134. PubMed ID: 27927775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
    Tariot PN
    J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmortem memantine concentrations.
    Bynum N; Poklis J; Garside D; Winecker R
    J Anal Toxicol; 2007 May; 31(4):233-6. PubMed ID: 17555649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memantine (Namenda, Forest Pharmaceuticals).
    Roman MW
    Issues Ment Health Nurs; 2009 Mar; 30(3):202. PubMed ID: 19291500
    [No Abstract]   [Full Text] [Related]  

  • 20. Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients?
    Sevilla C; Jiménez Caballero PE; Alfonso V; González-Adalid M
    Dement Geriatr Cogn Disord; 2009; 28(3):196-205. PubMed ID: 19738386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.